Digital footprints as a new translational approach for mental health care: a commentary
Tóm tắt
There is a crisis in mental health care, with more people suffering from psychiatric disorders than resources that are available for treatment, even though spending is substantial. Millions who suffer from addiction, psychosis, depression and suicidality are either untreated or inadequately treated and organized psychiatry is unable to reach them. Possibly as reflection of under-treatment of psychiatric disorders, the rates of suicide have risen: from 1999 through 2014, the age-adjusted suicide rate in the US increased 24%, from 10.5 to 13.0 per 100,000. Assessment of psychiatric symptoms in ongoing outpatient settings is costly, inadequate and unable to detect clinical changes over time. One’s digital phenotype is assessed through footprints left over as result of our interface with technology, including automated assessments of quantity and quality of social media activity, patterns and speed of device usage, and physiological data that is automatically collected, such as location, quantity and type of movement, heart rate, and sleep patterns. The use of digital footprints has been advocated for large-scale data collection that can facilitate psychiatric research in naturalistic settings. We highlight recent papers in Discover Mental Health addressing digital approaches to mental health and we also advance here the concept that digital footprints are ready for clinical use. However, before that happens there needs to be discussion on the appropriate boundaries between care that is driven by signals from digital footprints and the rights to privacy and self-determination.
Tài liệu tham khảo
Roehrig C. Mental disorders top the list of the most costly conditions In the United States: $201 Billion. Health Aff. 2016;35(6):1130–5.
Licinio J. A leadership crisis in American psychiatry. Mol Psychiatry. 2004;9(1):1.
Hoertel N, Franco S, Wall MM, Oquendo MA, Kerridge BT, Limosin F, et al. Mental disorders and risk of suicide attempt: a national prospective study. Mol Psychiatry. 2015;20(6):718–26.
Curtin SC, Warner M, Hedegaard H. Increase in suicide in the United States, 1999–2014. NCHS Data Brief. 2016;241:1–8.
Shen YI, Nelson AJ, Oberlin BG. Virtual reality intervention effects on future self-continuity and delayed reward preference in substance use disorder recovery: pilot study results. Discover Mental Health. 2022. https://doi.org/10.1007/s44192-022-00022-1.
Cavero V, Toyama M, Castro H, Couto MT, Brandt L, Quayle J, et al. Implementation and scalability of a digital intervention to reduce depressive symptoms in people with diabetes, hypertension or both in Brazil and Peru: a qualitative study of health system’s stakeholders’ perspectives. Discover Mental Health. 2022. https://doi.org/10.1007/s44192-022-00015-0.
Montag C, Elhai JD, Dagum P. On blurry boundaries when defining digital biomarkers: how much biology needs to be in a digital biomarker? Front Psychiatry. 2021;12: 740292.
Chan S, Godwin H, Gonzalez A, Yellowlees PM, Hilty DM. Review of use and integration of mobile apps into psychiatric treatments. Curr Psychiatry Rep. 2017;19(12):96.
Hui CY, Walton R, McKinstry B, Jackson T, Parker R, Pinnock H. The use of mobile applications to support self-management for people with asthma: a systematic review of controlled studies to identify features associated with clinical effectiveness and adherence. JAMIA. 2017;24(3):619–32.
McMillan KA, Kirk A, Hewitt A, MacRury S. A Systematic and integrated review of mobile-based technology to promote active lifestyles in people with type 2 diabetes. J Diabetes Sci Technol. 2017;11(2):299–307.
Cornet VP, Holden RJ. Systematic review of smartphone-based passive sensing for health and wellbeing. J Biomed Inform. 2018;77:120–32.
Jain SH, Powers BW, Hawkins JB, Brownstein JS. The digital phenotype. Nat Biotechnol. 2015;33(5):462–3.
Bidargaddi N, Musiat P, Makinen VP, Ermes M, Schrader G, Licinio J. Digital footprints: facilitating large-scale environmental psychiatric research in naturalistic settings through data from everyday technologies. Mol Psychiatry. 2017;22(2):164–9.
Markowetz A, Blaszkiewicz K, Montag C, Switala C, Schlaepfer TE. Psycho-informatics: big data shaping modern psychometrics. Med Hypotheses. 2014;82(4):405–11.
Hatfield D, McCullough L, Frantz SH, Krieger K. Do we know when our clients get worse? An investigation of therapists’ ability to detect negative client change. Clin Psychol Psychother. 2010;17(1):25–32.
Katschnig H. Quality of life in mental disorders: challenges for research and clinical practice. World Psychiatry. 2006;5(3):139–45.
Dagum P. Digital biomarkers of cognitive function. NPJ Digital Medicine. 2018 [in press].
Saeb S, Lattie EG, Schueller SM, Kording KP, Mohr DC. The relationship between mobile phone location sensor data and depressive symptom severity. PeerJ. 2016;4: e2537.
Madrid A, Smith D, Alvarez-Horine S, Saljooqi K, Dagum P, Mahableshwarkar A. Assessing anhedonia with quantitative tasks, digital and patient reported measures in a multicenter, double-blind trial with BTRX-246040 for the treatment of major depressive disorder. Neuropsychopharmacology. 2017;42:S372.
Insel TR. Join the disruptors of health science. Nature. 2017;551(7678):23–6.
Insel TR. Digital phenotyping: technology for a new science of behavior. JAMA. 2017;318(13):1215–6.
Christensen H, Cuijpers P, Reynolds CF 3rd. Changing the direction of suicide prevention research: a necessity for true population impact. JAMA Psychiat. 2016;73(5):435–6.
Bauer M, Glenn T, Monteith S, Bauer R, Whybrow PC, Geddes J. Ethical perspectives on recommending digital technology for patients with mental illness. Int J Bipolar Disord. 2017;5(1):6.
Berrouiguet S, Barrigon ML, Castroman JL, Courtet P, Artes-Rodriguez A, Baca-Garcia E. Combining mobile-health (mHealth) and artificial intelligence (AI) methods to avoid suicide attempts: the Smartcrises study protocol. BMC Psychiatry. 2019;19(1):277.
Kim A, Hsu M, Koire A, Baum ML. Incidental findings from deep phenotyping research in psychiatry: legal and ethical considerations. Camb Q Healthc Ethics. 2022;31(4):482–6.